Dinesh M. Kumar
CIK 1850439 · Chief Medical Officer · last filed 2026-04-03
Dinesh M. Kumar is a Chief Medical Officer who has filed 52 SEC Form 4 insider transactions across 3 companies since 2021. The most recent filing, for ASTH, was dated Apr 3, 2026. Across all open-market trades the lifetime net is −$7.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $15.2M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
ALHC price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
1668 S. GARFIELD AVENUE, 2ND FLOOR
ALHAMBRA, OH 91801
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ASTH | Chief Medical Officer | 177,655 | $37.23 | $6.61M | $0 | 13 | 2026-04-03 |
| Astrana Health, Inc. (AMEH) Delisted | See remarks | 117,762 | $40.82 | $4.81M | $0 | 1 | 2024-01-24 |
| ALHC | Chief Med & Operating Officer | 1,088,651 | $7.89 | $8.59M | -$7.51M | 25 | 2023-03-31 |
Recent Filings
52 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-04-03 | ASTH | Mixed | −22,680 | -$1.42M | EDGAR |
| 2026-03-09 | ASTH | Tax (F) | −1,697 | -$42.5K | EDGAR |
| 2026-01-27 | ASTH | Tax (F) | −10,759 | -$292.2K | EDGAR |
| 2026-01-05 | ASTH | Tax (F) | −5,102 | -$126.6K | EDGAR |
| 2025-09-09 | ASTH | Tax (F) | −1,694 | -$50.3K | EDGAR |
| 2025-07-02 | ASTH | Tax (F) | −6,831 | -$171.2K | EDGAR |
| 2025-06-06 | ASTH | Tax (F) | −1,656 | -$41.5K | EDGAR |
| 2025-04-30 | ASTH | Tax (F) | −828 | -$25.8K | EDGAR |
| 2025-03-07 | ASTH | Mixed | +18,835 | -$213.9K | EDGAR |
| 2025-01-27 | ASTH | Tax (F) | −7,210 | -$273.7K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.